SARS-CoV-2 is a novel coronavirus that infects patients through angiotensin-converting enzyme 2 (ACE2), which is the receptor protein located in cell membranes of the lung, leading to pneumonia reaction1. Here, ACE2 is linked to susceptibility to pneumonia measurement.